Phoenix PharmaLabs

12/08/2021

Op**te addiction is so very pernicious.

America can’t arrest its way out of a problem caused by the fundamental human need to connect.

09/16/2021

As part of Pain Awareness Month, Expertscape has recognized Dr. Lawrence Toll, Chief Neuropharmacologist at Phoenix PharmaLabs, as one of the top 1% experts in Opioid Receptors. He is ranked 39th out of more than 17,000 scientists in this area. Congratulations, Dr. Toll!

06/18/2021

Thanks to your support, our Netcapital offering was officially oversubscribed at the maximum of $1,070,000 just one day before the scheduled closing date yesterday! With this funding, we will continue to advance our research and testing to develop a pathway to pain therapy without the risk of addiction or side effects.

We'll continue to send important updates to all of our investors through email. If you're not on our email list, please reach out to bev@phoenixpharmalabs.com and she will get you added!

06/17/2021

Three more days left to invest in our mission to . Here's another reason to join us in our goal to create options for non-addictive pain relief.

Invest today 👇🏽

https://netcapital.com/companies/phoenix

06/15/2021

There are only FOUR more days left to invest in our mission to . Here's just *one* reason to join us in our goal to create options for non-addictive pain relief.

Invest today 👇🏽

https://netcapital.com/companies/phoenix

06/15/2021

Thanks to your continued support, were are thrilled to announce that yesterday we surpassed $1 million in our Netcapital raise. As many of you know, this is our second RegCF raise and our second time surpassing the $1 million milestone. We know we are onto something BIG, and could not be more excited to have so many friends backing our mission.

There are only 4 more days to invest (or reinvest!). Onwards + upwards!

https://netcapital.com/companies/phoenix

06/14/2021

There are only FIVE more days left to invest in our mission to . Here's just *one* reason to join us in our goal to create options for non-addictive pain relief.

Invest today 👇🏽

https://netcapital.com/companies/phoenix

04/01/2021

There is a significant need for non-addictive potent pain relief, and it's closer than you think.

Invest today:
https://netcapital.com/companies/phoenix

03/22/2021

Andy Gordon, Co-Founder of Early Investing and a strong supporter of Phoenix PharmaLabs, published another investment recommendation to his subscribers last week.

Two years ago when Andy first recommended Phoenix PharmaLabs as an investment, he noted that no other company in First Stage Investor’s portfolio has a higher upside. He points to what Phoenix has done to derisk the investment as one of the main reasons he continues to believe that the investment opportunity for Phoenix has reached a new level.

It's not too late to invest. Head to https://netcapital.com/companies/phoenix to join us in our mission to develop drugs that kill pain, not people.

03/11/2021

Be a part of the solution to end the opioid epidemic. Our non-addictive painkillers could change the trajectory of the opioid crisis, but we need your help to move these compounds into human clinical trials. Invest below:

https://netcapital.com/companies/phoenix

02/11/2021

If you missed yesterday's NetCapital Q&A with Phoenix PharmaLabs’ CEO Bill Crossman, you can catch the replay here:

https://www.youtube.com/watch?v=CYMq1PemP1g&t=3s

If you have questions that didn't get answered during the live Q&A, feel free to leave them below and we'll make sure to answer them!

02/08/2021

Join us for a live discussion on Wednesday, February 10th between CEO Bill Crossman and . It will be a great way to hear directly from Bill what is happening at Phoenix PharmaLabs and why we are excited about our future.

The discussion will start with some prepared questions, then allow potential investors to ask questions of the founders.

Sign up to register!

Tune in for a live discussion with Phoenix Pharama Labs, currently raising on Netcapital. We will start with some prepared questions, then allow potential investors to ask questions of the founders. More info: https://netcapital.com/companies/phoenix Questions? Email: lily.macomber@netcapital.com